Stephanie D Kovacs
Overview
Explore the profile of Stephanie D Kovacs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
133
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sun Y, Keskinocak P, Steimle L, Kovacs S, Wassilak S
Vaccine X
. 2024 Apr;
18:100476.
PMID: 38617838
Background: Despite the successes of the Global Polio Eradication Initiative, substantial challenges remain in eradicating the poliovirus. The Sabin-strain (live-attenuated) virus in oral poliovirus vaccine (OPV) can revert to circulating...
2.
Kishore N, Krow-Lucal E, Diop O, Jorba J, Avagnan T, Grabovac V, et al.
MMWR Morb Mortal Wkly Rep
. 2024 Apr;
73(13):278-285.
PMID: 38573841
The reliable and timely detection of poliovirus cases through surveillance for acute flaccid paralysis (AFP), supplemented by environmental surveillance of sewage samples, is a critical component of the polio eradication...
3.
Stehling-Ariza T, Wilkinson A, Diop O, Jorba J, Asghar H, Avagnan T, et al.
MMWR Morb Mortal Wkly Rep
. 2023 Jun;
72(23):613-620.
PMID: 37289657
Since the Global Polio Eradication Initiative (GPEI) was established in 1988, the number of wild poliovirus (WPV) cases has declined by >99.9%, and WPV serotypes 2 and 3 have been...
4.
Wilkinson A, Zaman K, Hoque M, Estivariz C, Burns C, Konopka-Anstadt J, et al.
Lancet Infect Dis
. 2023 May;
23(9):1062-1071.
PMID: 37178706
Background: Novel oral poliovirus vaccine type 2 (nOPV2) was developed by modifying the Sabin strain to increase genetic stability and reduce risk of seeding new circulating vaccine-derived poliovirus type 2...
5.
Estivariz C, Kovacs S, Mach O
Vaccine
. 2022 Apr;
41 Suppl 1:A113-A121.
PMID: 35365341
Delivering inactivated poliovirus vaccine (IPV) with oral poliovirus vaccine (OPV) in campaigns has been explored to accelerate the control of type 2 circulating vaccine-derived poliovirus (cVDPV) outbreaks. A review of...
6.
Zaman K, Kovacs S, VanderEnde K, Aziz A, Yunus M, Khan S, et al.
Vaccine
. 2021 Sep;
39(40):5814-5821.
PMID: 34481702
Background: After global oral poliovirus vaccine (OPV) cessation, the Strategic Advisory Group of Experts on Immunization (SAGE) currently recommends a two-dose schedule of inactivated poliovirus vaccine (IPV) beginning ≥14-weeks of...
7.
Kalkowska D, Pallansch M, Cochi S, Kovacs S, Wassilak S, Thompson K
Risk Anal
. 2020 Jul;
41(2):320-328.
PMID: 32632925
After the globally coordinated cessation of any serotype of oral poliovirus vaccine (OPV), some risks remain from undetected, existing homotypic OPV-related transmission and/or restarting transmission due to several possible reintroduction...
8.
Kalkowska D, Franka R, Higgins J, Kovacs S, Forbi J, Wassilak S, et al.
Risk Anal
. 2020 Apr;
41(2):289-302.
PMID: 32348621
Beginning in 2013, multiple local government areas (LGAs) in Borno and Yobe in northeast Nigeria and other parts of the Lake Chad basin experienced a violent insurgency that resulted in...
9.
Kovacs S, Mills B, Stergachis A
Malar J
. 2017 Jul;
16(1):282.
PMID: 28693488
Background: Malaria control efforts have been strengthened by funding from donor groups and government agencies. The Global Fund to Fight AIDS, Tuberculosis and the Malaria (Global Fund), the US President's...
10.
Kovacs S, van Eijk A, Sevene E, Dellicour S, Weiss N, Emerson S, et al.
PLoS One
. 2016 Nov;
11(11):e0164963.
PMID: 27824884
Given the high morbidity for mother and fetus associated with malaria in pregnancy, safe and efficacious drugs are needed for treatment. Artemisinin derivatives are the most effective antimalarials, but are...